Alison Gracom, PA

NPI: 1245496843
Total Payments
$384,559
2024 Payments
$126,193
Companies
39
Transactions
839
Medicare Patients
235
Medicare Billing
$48,568

Payment Breakdown by Category

Other$269,356 (70.0%)
Travel$80,526 (20.9%)
Consulting$18,833 (4.9%)
Food & Beverage$15,783 (4.1%)
Education$61.71 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $227,021 133 59.0%
Travel and Lodging $80,526 169 20.9%
Honoraria $42,334 18 11.0%
Consulting Fee $18,833 9 4.9%
Food and Beverage $15,783 507 4.1%
Education $61.71 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Corcept Therapeutics $325,269 454 $0 (2024)
RECORDATI_RARE_DISEASES_INC. $42,108 36 $0 (2024)
Xeris Pharmaceuticals, Inc. $11,597 56 $0 (2024)
ABBVIE INC. $1,580 91 $0 (2024)
Novo Nordisk Inc $582.94 38 $0 (2024)
Lilly USA, LLC $518.16 24 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $514.03 22 $0 (2024)
Merck Sharp & Dohme LLC $220.86 12 $0 (2023)
IBSA Pharma Inc. $216.44 7 $0 (2023)
AstraZeneca Pharmaceuticals LP $214.47 12 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $126,193 270 Corcept Therapeutics ($107,362)
2023 $94,878 237 Corcept Therapeutics ($91,801)
2022 $66,039 176 Corcept Therapeutics ($59,750)
2021 $97,448 156 Corcept Therapeutics ($66,355)

All Payment Transactions

839 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
12/20/2024 RECORDATI_RARE_DISEASES_INC. ISTURISA (Drug) Food and Beverage In-kind items and services $21.38 General
Category: ENDOCRINE AGENT
12/19/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Honoraria Cash or cash equivalent $1,050.00 General
Category: Adrenal steroidogenesis inhibitor
12/19/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Honoraria Cash or cash equivalent $1,050.00 General
Category: Adrenal steroidogenesis inhibitor
12/19/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Honoraria Cash or cash equivalent $525.00 General
Category: Adrenal steroidogenesis inhibitor
12/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.99 General
Category: NEUROSCIENCE
12/12/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Food and Beverage In-kind items and services $7.10 General
Category: Adrenal steroidogenesis inhibitor
12/11/2024 Corcept Therapeutics Korlym (Drug) Consulting Fee Cash or cash equivalent $340.00 General
Category: Endocrinology
12/09/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $32.79 General
Category: NEUROSCIENCE
12/05/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage In-kind items and services $6.78 General
Category: Endocrinology
12/03/2024 ABBVIE INC. SYNTHROID (Drug), UBRELVY Food and Beverage In-kind items and services $15.00 General
Category: IMMUNOLOGY
12/02/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Honoraria Cash or cash equivalent $1,050.00 General
Category: Adrenal steroidogenesis inhibitor
12/02/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Travel and Lodging Cash or cash equivalent $27.47 General
Category: Adrenal steroidogenesis inhibitor
11/26/2024 ABBVIE INC. UBRELVY (Drug), SYNTHROID Food and Beverage In-kind items and services $17.85 General
Category: NEUROSCIENCE
11/22/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Food and Beverage In-kind items and services $19.50 General
Category: Adrenal steroidogenesis inhibitor
11/20/2024 Corcept Therapeutics Korlym (Drug) Travel and Lodging Cash or cash equivalent $40.00 General
Category: Endocrinology
11/20/2024 Corcept Therapeutics Korlym (Drug) Travel and Lodging Cash or cash equivalent $40.00 General
Category: Endocrinology
11/20/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage Cash or cash equivalent $37.16 General
Category: Endocrinology
11/20/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage Cash or cash equivalent $33.82 General
Category: Endocrinology
11/20/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage Cash or cash equivalent $28.72 General
Category: Endocrinology
11/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.23 General
Category: NEUROSCIENCE
11/20/2024 Corcept Therapeutics Korlym (Drug) Travel and Lodging Cash or cash equivalent $25.59 General
Category: Endocrinology
11/20/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage Cash or cash equivalent $8.15 General
Category: Endocrinology
11/15/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Food and Beverage In-kind items and services $8.91 General
Category: Adrenal steroidogenesis inhibitor
11/14/2024 RECORDATI_RARE_DISEASES_INC. ISTURISA (Drug) Honoraria Cash or cash equivalent $2,100.00 General
Category: ENDOCRINE AGENT
11/14/2024 RECORDATI_RARE_DISEASES_INC. ISTURISA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $75.60 General
Category: ENDOCRINE AGENT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 130 232 $55,425 $27,432
2022 3 105 170 $41,425 $21,136
Total Patients
235
Total Services
402
Medicare Billing
$48,568
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 82 181 $40,725 $21,778 53.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 17 17 $5,950 $2,403 40.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 18 21 $4,200 $1,701 40.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 13 13 $4,550 $1,551 34.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 66 129 $29,025 $16,076 55.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 28 28 $9,800 $3,908 39.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 11 13 $2,600 $1,152 44.3%

About Alison Gracom, PA

Alison Gracom, PA is a Medical healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245496843.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alison Gracom, PA has received a total of $384,559 in payments from pharmaceutical and medical device companies, with $126,193 received in 2024. These payments were reported across 839 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($227,021).

As a Medicare-enrolled provider, Gracom has provided services to 235 Medicare beneficiaries, totaling 402 services with total Medicare billing of $48,568. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Medical
  • Other Specialties Medical
  • Location Irvine, CA
  • Active Since 08/03/2008
  • Last Updated 02/07/2022
  • Taxonomy Code 363AM0700X
  • Entity Type Individual
  • NPI Number 1245496843

Products in Payments

  • Korlym (Drug) $325,269
  • RECORLEV (Drug) $10,874
  • ISTURISA (Drug) $10,221
  • VRAYLAR (Drug) $796.79
  • JARDIANCE (Drug) $611.33
  • GVOKE HYPOPEN (Drug) $525.00
  • UBRELVY (Drug) $391.67
  • SIGNIFOR LAR (Drug) $239.55
  • SYNTHROID (Drug) $215.99
  • Ozempic (Drug) $202.94
  • GVOKE PFS (Drug) $197.91
  • FARXIGA (Drug) $193.76
  • BELSOMRA (Drug) $178.35
  • Wegovy (Drug) $162.11
  • QULIPTA (Drug) $141.09
  • Tymlos (Drug) $136.58
  • TRULICITY (Drug) $127.75
  • QUVIVIQ (Drug) $127.46
  • EMGALITY (Drug) $126.78
  • Licart (Drug) $125.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Doctors in Irvine